49662-0
HIV nonnucleoside reverse transcriptase susceptibility panel by Phenotype method
Active
30276-0 Delavirdine [Susceptibility] by Phenotype method
Part Descriptions
LP21173-7 Delavirdine
A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.
Source: National Library of Medicine, MeSH 2006
LP21173-7 Delavirdine
Delavirdine is a Nonnucleoside Reverse Transcriptase Inhibitor (Non-NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Delavirdine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Panel Name
- Short Name
- Delavirdine Islt Phenotyp
- Display Name
- Delavirdine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Delavirdine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.19
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41246-6 | DelavirdineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Delavirdin: |
| es-ES | Spanish (Spain) | Delavirdina: |
| es-AR | Spanish (Argentina) | delavirdina: |
| es-MX | Spanish (Mexico) | Delavirdina: |
| et-EE | Estonian (Estonia) | Delavirdiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-BE | French (Belgium) | Délavirdine: |
| fr-FR | French (France) | Delavirdine: |
| fr-CA | French (Canada) | Délavirdine: |
| it-IT | Italian (Italy) | Delavirdina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 델라비르딘: |
| nl-NL | Dutch (Netherlands) | delavirdine: |
| pt-BR | Portuguese (Brazil) | Delavirdina: Synonyms: Rescriptor; |
| tr-TR | Turkish (Turkey) | Delavirdin: |
| zh-CN | Chinese (China) | 地拉韦定: Synonyms: Dlv; |
30277-8 Efavirenz [Susceptibility] by Phenotype method
Part Descriptions
LP21310-5 Efavirenz
Efavirenz is a Nonnucleoside Reverse Transcriptase Inhibitor (Non-NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP21310-5 Efavirenz
Efavirenz (EFV, brand names Sustiva and Stocrin) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Efavirenz
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Panel Name
- Short Name
- Efavirenz Islt Phenotyp
- Display Name
- Efavirenz Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Efavirenz
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19676
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41247-4 | EfavirenzSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | Efavirenz: |
| es-ES | Spanish (Spain) | Efavirenz: |
| es-AR | Spanish (Argentina) | efavirenz: |
| es-MX | Spanish (Mexico) | Efavirenz: |
| fr-FR | French (France) | Éfavirenz: |
| fr-BE | French (Belgium) | Éfavirenz: |
| fr-CA | French (Canada) | Éfavirenz: |
| it-IT | Italian (Italy) | Efavirenz: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 에파비렌즈: |
| nl-NL | Dutch (Netherlands) | efavirenz: |
| pt-BR | Portuguese (Brazil) | Efavirenz: Synonyms: Sustiva; |
| tr-TR | Turkish (Turkey) | Efavirenz: |
| zh-CN | Chinese (China) | 依法韦恩茨: Synonyms: EFV; |
72558-0 Etravirine [Susceptibility] by Phenotype method
Part Descriptions
LP68431-3 Etravirine
Etravirine (brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTIs). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Etravirine is marketed by Tibotec, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for patients with established resistance to other drugs, making it the 30th anti-HIV drug approved in the United States and the first to be approved in 2008. It was also approved for use in Canada on April 1, 2008.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Etravirine
LP68431-3 Etravirine
Etravirine (ETR) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Fully-Specified Name
- Component
- Etravirine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Panel Name
- Short Name
- Etravirine Islt Phenotyp
- Display Name
- Etravirine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Etravirine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.42
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 19596
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41387-8 | EtravirineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Etravirina: |
| es-MX | Spanish (Mexico) | Etravirina: |
| et-EE | Estonian (Estonia) | Etraviriin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-FR | French (France) | Étravirine: |
| fr-BE | French (Belgium) | Etravirine: |
| fr-CA | French (Canada) | Etravirine: |
| it-IT | Italian (Italy) | Etravirina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | etravirine: |
| pt-BR | Portuguese (Brazil) | Etravirine: |
| tr-TR | Turkish (Turkey) | Etravirin: |
| zh-CN | Chinese (China) | 依曲韦林: Synonyms: Intelence; |
30275-2 Nevirapine [Susceptibility] by Phenotype method
Part Descriptions
LP21317-0 Nevirapine
Nevirapine is a Nonnucleoside Reverse Transcriptase Inhibitor (Non-NRTI) antiretroviral drug used in the treatment of HIV. Drug resistance reports assist with treatment decisions.
Source: Regenstrief Institute
LP21317-0 Nevirapine
Nevirapine, also marketed under the trade name Viramune (Boehringer Ingelheim), is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.
As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Wikipedia
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Nevirapine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Panel Name
- Short Name
- Nevirapine Islt Phenotyp
- Display Name
- Nevirapine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Nevirapine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.04
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 19321
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41245-8 | NevirapineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Nevirapina: |
| es-MX | Spanish (Mexico) | Nevirapina: |
| es-AR | Spanish (Argentina) | nevirapina: |
| et-EE | Estonian (Estonia) | Nevirapiin: Synonyms: Isolaat Juhuslik Tundlikkus |
| fr-FR | French (France) | Névirapine: |
| fr-BE | French (Belgium) | Névirapine: |
| fr-CA | French (Canada) | Névirapine: |
| it-IT | Italian (Italy) | Nevirapina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| ko-KR | Korean (Korea, Republic Of) | 네비라핀: |
| nl-NL | Dutch (Netherlands) | nevirapine: |
| pt-BR | Portuguese (Brazil) | Nevirapina: Synonyms: Viramune; |
| tr-TR | Turkish (Turkey) | Nevirapin: |
| zh-CN | Chinese (China) | 奈韦拉平: Synonyms: NVP 分离物; |
72557-2 Rilpivirine [Susceptibility] by Phenotype method
Part Descriptions
LP135443-2 Rilpivirine
Rilpivirine (brand name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, http://en.wikipedia.org/wiki/Rilpivirine
Fully-Specified Name
- Component
- Rilpivirine
- Property
- Susc
- Time
- Pt
- System
- Isolate
- Scale
- OrdQn
- Method
- Phenotyping
Additional Names
- Panel Name
- Short Name
- Rilpivirine Islt Phenotyp
- Display Name
- Rilpivirine Phenotype method [Susc]
- Consumer Name Alpha Get Info
- Susceptibility to Rilpivirine
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.42
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 17396
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 49665-3 | HIV susceptibility panel by Phenotype method |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG41382-9 | RilpivirineSusc| |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-MX | Spanish (Mexico) | Rilpivirina: |
| es-ES | Spanish (Spain) | Rilpivirina: |
| fr-FR | French (France) | Rilpivirine: |
| fr-CA | French (Canada) | Rilpivirine: |
| it-IT | Italian (Italy) | Rilpivirina: Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale |
| nl-NL | Dutch (Netherlands) | rilpivirine: |
| pt-BR | Portuguese (Brazil) | Rilpivirine: |
| tr-TR | Turkish (Turkey) | Rilpivirin: |
| zh-CN | Chinese (China) | 利匹韦林: Synonyms: 4-[4-[4-[(E)-2-Cyanovinyl]-2,6-dimethylphenylamino]pyrimidin-2-ylamino]benzonitrile; |